Merck, Pfizer, J&J lead drug stocks higher

Merck & Co. leads drug stocks higher, as the pharmaceutical giant marks the first day since the closure of its $41 billion merger with rival Schering-Plough.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.